Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

Approval Number

SIN17104P

Drug Name

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

Product Name

BILAXTEN TABLET 20 MG (PHARMACY ONLY)

Approval Date

October 2, 2024

Registrant

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

Registrant

A. MENARINI SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

R06AX29

Manufacturer Information

Pharmaceutical Manufacturer

A. MENARINI SINGAPORE PTE. LTD.

Manufacturers

A. MENARINI MANUFACTURING LOGISTICS AND SERVICES S.r.l.

Active Ingredients

Ingredient Name

BILASTINE

Strength

20.00 mg

Drug MonographBilastine

Documents

Patient Information Leaflets

Bilaxten Tablet (Pharmacy Only) PIL.pdf

Approved: October 2, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy